Rarely, some nanoparticles that enter a cell undergo an unexpected transformation, acquiring a coating known as a “condensate ...

MONTREAL, April 16, 2026--"This research project, benefiting from a budget of $2.2 million, one of six jointly supported by ...

MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, celebrates its 10th anniversary, a decade marked by breakthroughs that ...

Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how ...

Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how ...

Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: BofA Securities 2026 Health Care Conference Wednesday, May 13, 2026 9:20 a.m. PT - Steve Willoughby, ...

Revvity, Inc. (NYSE: RVTY), today announced that it will release its first quarter 2026 financial results prior to market ...

Advancing discovery from lab to life through AI-driven insights, imaging, and end-to-end workflowsWALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is showcasing its latest innovations in cancer research ...

Researchers developed a new RNA sequencing strategy that can reveal how genetic variants disrupt gene function and improve the diagnosis of rare diseases. The study team demonstrated that this ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

The editorial, "Dynamics-driven medical big data mining: dynamic approaches to early disease forecasting and individualized care," published in ...

FB301 was safe and well tolerated in healthy female subjects, with all primary and secondary endpoints met; Clinically meaningful microbiome modulation observed, including signifi ...